Patient with end stage renal disease have characteristics in common with heart failure patients, and volume overload in heart failure is associated with poorer outcomes. Fluid removal during the hemodialysis (HD) is the cornerstone of volume management in this population. The objective of this study is to assess the long-term prognostic effect of interdialytic fluid retention (IDFR) and its relationship with cardiovascular (CV) events in incident HD patients who newly started dialysis. IDFR is defined as the difference between the predialysis weight and the weight at the end of the previous dialysis session, and it mainly reflects the consequence of salt and water intake between two consecutive dialysis sessions. We retrospectively reviewed the 172 patients who newly started and maintained HD over 6 months at Gachon University Gil Hospital between 1 January 2003 and 31 December 2008. The average data were collected for 3 months during the beginning period, including total IDFR and IDFR/dry weight (IDFR%), nutritional parameters, blood pressure, and other biochemical parameters. Patients were classified into 3 cohorts according to the tertile of IDFR%; low (T1; ≤ 3.21%), intermediate (T2; 3.21%-4.56%), and high (T3; ≥ 4.56%). The high IDFR% group showed higher prevalence of diabetes and better nutritional status. The adjusted odds ratio for CV events was 1.562 (95% confidence interval, 1.026-2.378) for high IDFR% group, compared with the low IDFR% group. In incident HD patients, greater IDFR% soon after HD initiation showed an independent association with higher risk for CV events.
Patient with end-stage renal disease have characteristics in common with heart failure patients. Both populations have high mortality, and the most common cause is a cardiovascular (CV) event. Fluid retention is a common complication in hemodialysis (HD) and heart failure patients and is associated with poorer outcome (KalantarZadeh et al. 2006) . It has been suggested that CV events in both patient populations have similar pathophysiology (Burton et al. 2009a (Burton et al. , 2009b . Interdialytic fluid retention (IDFR), the difference between the predialysis weight and the weight at the end of the previous dialysis session, is mainly the result of salt and water intake between two consecutive dialysis sessions. Large amount of fluid removal during HD is necessary to maintain volume control in patients with greater IDFR, but it promotes non-physiological fluid shifts and hemodynamic instability. Therefore, these factors contribute to tissue ischemia, myocardial stunning, arrhythmia, and cardiac sudden death (Sharpe 2003; Burton et al. 2009a Burton et al. , 2009b . Although higher IDFR is associated with better nutritional indices, it predisposes to volume overload, which causes abnormal ventricular remodeling in heart failure (Sherman et al. 1995; Testa and Beaud 1998; Sezer et al. 2002; Bellizzi et al. 2003) . Despite obvious biological plausibility, the association between IDFR and CV morbidity and mortality has not been well studied. Excessive IDFR was an independent predictor of mortality in a number of observational studies (Lopez-Gomez et al. 2005; Kalantar-Zadeh et al. 2009; Flythe et al. 2011) . However, all of these studies were conducted in the longterm maintenance HD patients. The present study examined the relationship between IDFR during the early period after HD initiation and consequent CV outcomes in incident HD patients.
Subjects and Methods

Study population
This is a retrospective observational study of incident HD patients. The study population included all adults, 18 years or older, who newly started and maintained the HD treatment over 6 months between 1 January 2003 and 31 December 2008 at Gachon University Gil Hospital. Each participant was enrolled in the study on the date of the first HD treatment. Patients who were lost to follow-up or who experienced CV events during the first 6 months were excluded. The study was reviewed and approved by the Ethics Committee of Gachon University of Medicine and Science.
Measurement of covariates
Blood pressure (BP) was evaluated just prior to mid-week HD sessions, from which blood chemistry analyses were obtained. Predialysis BP was measured by trained health care professionals or automated monitors, with the patient in a supine position for 5 minutes prior to measuring BP. The upper arm opposite the access side was used. Intact parathyroid hormone (iPTH) was determined by using chemiluminescent immunoassay (ADVIA Centaur® XP, Siemens, Germany).
The parameters examined included age, mean arterial pressure, body mass index, single pool Kt/V (spKt/V), smoking status, previous CVD history and medication history. Other parameters that were measured, using standard laboratory techniques, included levels of hemoglobin, albumin, calcium, phosphorus, total cholesterol, triglyceride, HDL cholesterol, and LDL cholesterol.
CV events were defined as new development of myocardial infarction, angina, other ischemic heart disease, heart failure, cerebrovascular accident, or peripheral vascular disease. Coronary angioplasty or peripheral revascularization procedure were also included in the definition of CV event.
Interdialytic fluid retention measurement
HD patients usually gain weight between two consecutive dialysis treatments, owing almost entire to fluid retention. Owing to the intermittent nature of HD, the patient oscillates between a highweight ''wet'' state, just before the session, and a low-weight ''dry'' state just at the end of the session. Therefore, the amount of fluid that is ultrafiltrated during a HD session is equivalent to the magnitude of weight gain immediately before the session. Because the ultrafiltration amount was varied during the first 3 month, to mitigate the interpersonal variability during the periods, we used the pre-and post-HD weights for each patient during months 4 to 6 to calculate 3-month averages. According to the previous report (Lopez-Gomez et al. 2005) , IDFR is expressed as the difference between the predialysis weight and the weight at the end of the previous dialysis session, and to mitigate individual variation, IDFR% is obtained using the percentage relationship between the average IDFR and the patient's dry weight. Dry weight means that the post-dialysis weight at which the patient is and remains normotensive until the next dialysis, that is, the lowest weight tolerated without developing low blood pressure. Patients were classified into 3 cohorts according to the tertile of IDFR%; low (T1; ≤ 3.21%), intermediate (T2; 3.21%-4.56%), and high (T3; ≥ 4.56%). The body mass index was calculated as the post-HD (dry) weight divided by height squared.
Laboratory measures
Most laboratory values, including complete blood cell counts and serum levels of serum urea nitrogen, creatinine, albumin, calcium, phosphorus, total cholesterol, triglyceride, and HDL and LDL cholesterol, were measured monthly. Serum ferritin and intact parathyroid hormone were measured at least quarterly. Single-pool Kt/V and normalized protein nitrogen appearance (nPNA) were measured monthly. The average values of all measurements for 3 months coincident with IDFR were used for the analysis.
Statistical methods
Continuous variables were tested for normality using the Kolmogorov-Smirnov test before further statistical analysis. Categorical variables are expressed as frequencies; normally distributed variables as mean ± standard deviation. Comparisons between groups were performed using the analysis of variance, unpaired Student's t-test, or Chi-square test, depending on the variable characteristics. Cumulative survival curves were used to calculate the probability of high risk for CV outcomes. Cumulative survival curves were compared using the log rank test. Associations between IDFR with CV outcomes were evaluated in multiple analyses with the Cox proportional regression (95% confidence interval). Values of P < 0.05 were taken to indicate statistical significance. SPSS version 15.0 for Windows (SPSS Inc., Chicago, IL, USA) was used for the statistical analysis.
Results
Baseline characteristics
A total of 305 incident HD patients newly started dialysis in our clinic between 2003 and 2008. After excluding patients who did not maintain HD treatment for 6 month and those with CV events or all-cause mortality within the first 6 months, 172 HD patients remained. The mean age of the patients was 56.8 years, and 53.8% were male patients. Using the median value of the average IDFR for 3month (months 4 to 6 after HD initiation), we calculated IDFR/dry weight (IDFR%) and divided the patients into 3 groups according to tertile of IDFR (%), low (T1; ≤ 3.21 kg), intermediate (T2; 3.21%-4.56%), and high (T3; ≥ 4.56%). Table  1 compares the baseline characteristics of the patients among those groups. Compare with the lower IDFR% group, the high IDFR% group had a higher prevalence of diabetes mellitus (58.9 vs. 65.5 vs. 68.4%, respectively; P = 0.046), a higher phosphorus (3.9 ± 1.2 vs. 4.2 ± 1.1 vs. 4.3 ± 1.2 mg/dl, respectively; P = 0.048), and higher nPNA levels (1.3 ± 0.3 vs. 1.6 ± 0.4 vs. 1.8 ± 0.4 g/kg/day, respectively; P < 0.001). Daily urine volume and diuretics use were similar among those groups.
CV outcomes according to the IDFR
CV events were observed 6 months after HD initiation. The patients were followed for up to 96 months or until death. The mean time of observation was 30.2 ± 23.5 months. CV events occurred in 51 patients after HD initiation. There were 28 overall deaths and 10 CV deaths. The cumulative incidence rate for CV events demonstrated that high IDFR% group was associated with a higher risk for CV events (Fig. 1 ) and all-cause and CV mortalities also increased in high IDFR% group (Fig. 2) .
Prognostic factors for cardiovascular events
Based on a univariate Cox regression analysis (Table  2) , the following variables were associated with CV events: high IDFR% [odds ratio (OR), 1.568; 95% confidence interval (CI), 1.050-2.341; P = 0.028], hemoglobin (OR, 0.750; 95% CI, 0.541-1.040; P = 0.044), total cholesterol (OR, 1.011; 95% CI, 1.001-1.022; P = 0.038), and LDL cholesterol (OR, 1.015; 95% CI, 1.003-1.027; P = 0.016). After adjustment of confounding factors, the odds ratio for CV events was 1.562 (95% confidence interval, 1.026-2.378) for high IDFR% group, compared with the low IDFR% group (Table 3) . LDL cholesterol (OR, 1.011; 95% CI, 1.000-1.022; P = 0.046) were also associated with 3.9 ± 1.5 2.3 ± 0. Creatinine (mg/dl) 7.2 ± 2.5 7.5 ± 2.8 7.1 ± 2. 
Discussion
Among 172 incident HD patients, 33% gained ≥ 4.56% IDFR of dry weight between two consecutive HD sessions during the early period after HD initiation. Diabetic patients and those with better nutritional status showed high IDFR%. After adjustment for these confounding variables, high IDFR% was associated with increased risk for CV events, based on about 30 months of observation.
The CV mortality of HD patient is 5 to 30 times that of people of the same age, race, and gender in the general population (Sarnak et al. 2003) . Many traditional CV disease risk factors, including older age, male gender, hypertension, higher levels of LDL cholesterol, diabetes, smoking, and family history of CVD, also contribute to CV mortality in HD patients, but some risk factors have an opposite influence (Kalantar-Zadeh et al. 2003; Coresh et al. 2004) . Recently, nontraditional risk factors such as anemia, extracellular volume overload, electrolyte imbalance, oxidative stress, inflammation, and malnutrition have received attention. Observational studies have demonstrated that high interdialytic weight gain may be an independent predictor of mortality (Leggat et al. 1998 ; Saran et Cumulative CV survival rate (A) and overall survival rate (B) in HD patients according to IDFR% grade.
al. 2003)
. As the magnitude of ultrafiltration during HD represents interdialytic weight gain or fluid retention, a higher ultrafiltration volume is likely to be associated with CV events, which are the main cause of mortality in HD patient. However, the association of IDFR and CV events has seldom been described in incident HD patients. In this report, we demonstrated that higher IDFR in incident HD during the early period after HD initiation is associated with increased risk for CV events. Kalantar-Zadeh et al. (2009) reported that younger age, male gender, longer dialysis history, diabetic status, larger body size, higher protein intake, and better nutrition were associated with a higher likelihood of high IDFR. Meanwhile, Flythe et al. (2011) observed that younger age, congestive heart failure, oliguria, higher systolic BP, higher serum creatinine, higher phosphorus, and a lower hematocrit were present in a higher ultrafiltration group. LopezGomez et al. (2005) found a direct association between greater interdialytic weight gain and better nutritional status in HD patients. In the present study, higher nPNA and higher phosphorus levels, which represent higher protein intake and better nutrition, as well as diabetic mellitus, were associated with higher IDFR; our result are similar to the findings of previous studies, except that age was not associated with higher IDFR in our study. Although higher IDFR was associated with CV events, the CV events were not attributable to elevated nPNA or high phosphorus per se. In contrast to the association between overnutrition and poor outcomes in the general population, undernutrition is strongly correlated with increased morbidity and mortality, including higher risk for CV events, in dialysis patients (Kopple 1997; KalantarZadeh et al. 2003) . Furthermore, better nutrition is not associated with mortality, but rather has a protective effect on survival in dialysis patients. Therefore, the association between increased IDFR and mortality may be confounded and overshadowed by the link between nutrition and CV outcomes (Kalantar-Zadeh et al. 2009 ).
Higher IDFR leads to repeated volume overload and can cause abnormal ventricular remodeling and compensatory mechanisms, resulting in CV events, including heart failure (Sharpe 2003) . In addition, patients with higher IDFR undergo a higher ultrafiltration rate, with an increased likelihood of intradialytic hypotension. Burton et al. demonstrated that higher ultrafiltration volume and intradialytic hypotension are independent risk factors for the development of HD-induced myocardial stunning (Burton et al. 2009a) , and repeated myocardial stunning in consecutive HD treatment leads to reduced left ventricular function, consistent with hibernating myocardium and fibrosis (Wijns et al. 1998; Burton et al. 2009b ). These pathophysiological aspects provide a possible mechanism for an association between higher IDFR and CV events. However, further study is needed to elucidate the detailed mechanism, as interdialytic hypotension can also result in myocardial ischemia, infarction, and stroke.
The present study has several limitations. These include its small sample size, its observational and retrospective nature, and its lack of a more precise measure of fluid retention, such as bioelectrical impendence analysis. In addition, there was a lack of data on dietary fluid intake and the correlation between IDFR% and nutritional status. However, we controlled for biochemical measures of nutritional status, including nPNA and serum levels of albumin, ferritin, creatinine and phosphorus. Moreover, to minimize measurement variability, our analyzed were based on 3-month averages of IDFR% values adjusted by dry weight and most biochemical measurements.
In summary, we demonstrated an association between IDFR% and CV outcomes in incident HD patients. Our data suggest that greater amount of fluid gain during the early period after HD initiation is associated with poor prognosis in patients who have newly started HD. Longitudinal studies with a larger number of subjects are needed to explore the possible mechanistic link between IDFR and CV mortality and to investigate whether effective strategies for mitigating fluid retention can improve CV outcomes in incident HD patients.
